Cardiovascular protection by SGLT2 inhibitors: an integrative review of mechanistic networks, clinical evidence, and safety considerations

• by Ziyun Wang, Yijin Wang, Wangning Shangguan, Tao Li

• June 9, 2026

Case Report: Selective metal cell excision during open TAVR implantation preserves coronary access while maintaining valve integrity and function

• by Julia E. Katter, John Paul Tannous, Katherine A. Roberts, Shawn M. Ahmad, Michael N. Young, Henry J. Tannous

• May 29, 2026

SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity

• by Barbara Pala, Mariagrazia Piscione, Maria Carmela Di Marcantonio, Francesco Cribari, Roberta Vitale, Thomas Baldi, Ada Popolo, Gabriella Mincione

• June 9, 2026

Recognizing the Transition to Advanced Heart Failure Earlier

Despite major advances in guideline-directed medical therapy (GDMT), worsening heart failure continues to drive significant morbidity, repeat hospitalizations and healthcare utilization worldwide.

• May 27, 2026

• 6 min